Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP Study)

Simple item page
dc.contributor.authorCarson, K.
dc.contributor.authorSmith, B.
dc.contributor.authorBrinn, M.
dc.contributor.authorPeters, M.
dc.contributor.authorFitridge, R.
dc.contributor.authorKoblar, S.
dc.contributor.authorJannes, J.
dc.contributor.authorSingh, K.
dc.contributor.authorVeale, A.
dc.contributor.authorGoldsworthy, S.
dc.contributor.authorLitt, J.
dc.contributor.authorEdwards, D.
dc.contributor.authorHnin, K.
dc.contributor.authorEsterman, A.
dc.date.issued2014
dc.descriptionFirst published online: July 16, 2014
dc.description.abstractINTRODUCTION: Inpatient medical settings offer an opportunistic environment for initiating smoking cessation interventions to patients reflecting on their health. Current evidence has shown the superior efficacy of varenicline tartrate (VT) for smoking cessation compared with other tobacco cessation therapies; however, recent evidence also has highlighted concerns about the safety and tolerability of VT. Given these apprehensions, we aimed to evaluate the safety and effectiveness of VT plus quitline-counseling compared to quitline-counseling alone in the inpatient medical setting. METHODS: Adult patients (n = 392, 20-75 years) admitted with a smoking-related illnesses to 3 hospitals were randomized to receive either 12 weeks of varenicline tartrate (titrated from 0.5mg daily to 1mg twice daily) plus quitline-counseling (VT+C), (n = 196) or quitline-counseling alone (n = 196). RESULTS: VT was well tolerated in the inpatient setting among subjects admitted with acute smoking-related illnesses (mean age 52.8±2.89 and 53.7±2.77 years in the VT+C and counseling alone groups, respectively). The most common self-reported adverse event during the 12-week treatment phase was nausea (16.3% in the VT+C group compared with 1.5% in the counseling alone group). Thirteen deaths occurred during the study period (n = 6 were in the VT+C arm compared with n = 7 in the counseling alone arm). All of these subjects had known comorbidities or developed underlying comorbidities. CONCLUSIONS: VT appears to be a safe and well-tolerated opportunistic treatment for inpatient smokers who have related chronic disease. Based on the proven efficacy of varenicline from outpatient studies and our recent inpatient evidence, we suggest it be considered as part of standard care in the hospital setting.
dc.description.statementofresponsibilityKristin Veronica Carson, Brian James Smith, Malcolm Philip Brinn, Matthew J. Peters, Robert Fitridge, Simon A. Koblar, Jim Jannes, Kuljit Singh, Antony J. Veale, Sharon Goldsworthy, John Litt, David Edwards, Khin Moe Hnin, Adrian Jeffrey Esterman
dc.identifier.citationNicotine and Tobacco Research, 2014; 16(11):1495-1502
dc.identifier.doi10.1093/ntr/ntu112
dc.identifier.issn1462-2203
dc.identifier.issn1469-994X
dc.identifier.orcidCarson, K. [0000-0001-9966-9289]
dc.identifier.orcidFitridge, R. [0000-0001-6258-5997]
dc.identifier.orcidKoblar, S. [0000-0002-8667-203X]
dc.identifier.orcidJannes, J. [0000-0003-1440-2572]
dc.identifier.orcidSingh, K. [0000-0001-9657-9923]
dc.identifier.orcidEsterman, A. [0000-0001-7324-9171]
dc.identifier.urihttp://hdl.handle.net/2440/91717
dc.language.isoen
dc.publisherOxford University Press (OUP)
dc.rights© The Author 2014. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.
dc.source.urihttps://doi.org/10.1093/ntr/ntu112
dc.subjectHumans
dc.subjectHeadache
dc.subjectNausea
dc.subjectBenzazepines
dc.subjectQuinoxalines
dc.subjectNicotinic Agonists
dc.subjectTreatment Outcome
dc.subjectHospitalization
dc.subjectSmoking
dc.subjectSmoking Cessation
dc.subjectCounseling
dc.subjectAdult
dc.subjectAged
dc.subjectMiddle Aged
dc.subjectFemale
dc.subjectMale
dc.subjectYoung Adult
dc.subjectVarenicline
dc.titleSafety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP Study)
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications